We are live on ! Find out more
MP

MSD Partners Portfolio holdings

AUM $76.8M
1-Year Est. Return 34.91%
This Fund
S&P 500
This Quarter Est. Return
-27.24%
1 Year Est. Return
-34.91%
3 Year Est. Return
+3.5%
5 Year Est. Return
-35.03%
10 Year Est. Return
+34.75%
AUM
$1.24B
AUM Growth
-$383M
Cap. Flow
-$46M
Cap. Flow %
-3.72%
Top 10 Hldgs %
88.64%
Holding
94
New
1
Increased
4
Reduced
3
Closed
11

Top Buys

Rank Stock Value
1
APEI icon
American Public Education
APEI
+$1.37M

Top Sells

Rank Stock Value
1
ASTL icon
Algoma Steel
ASTL
+$39M
2
OCUL icon
Ocular Therapeutix
OCUL
+$4.09M
3
GDYN icon
Grid Dynamics Holdings
GDYN
+$4.06M
4
BRPMU
B. Riley Principal 150 Merger Corp. Unit
BRPMU
+$4.04M
5
NNN icon
NNN REIT
NNN
+$3.19M

Sector Composition

Rank Sector Weight
1 Industrials 52.32%
2 Miscellaneous 32.72%
3 Financials 5.18%
4 Healthcare 3.14%
5 Communication Services 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGSWW
76
DELISTED
GeneDx Holdings Warrant
WGSWW
$23K ﹤0.01%
100,000
– –
BKKT.WS icon
77
Bakkt Inc Warrants
BKKT.WS
$104K
$20K ﹤0.01%
33,333
– –
WE.WS
78
DELISTED
WeWork Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
WE.WS
$17K ﹤0.01%
50,000
– –
AUROW
79
Aurora Innovation Warrant
AUROW
$108M
$12K ﹤0.01%
25,000
– –
TLSIW icon
80
TriSalus Life Sciences Warrant
TLSIW
$30.7M
$8K ﹤0.01%
133,333
– –
ETHZW
81
DELISTED
ETHZilla Corp Warrant
ETHZW
$5K ﹤0.01%
100,000
– –
CPS icon
82
Cooper-Standard Automotive
CPS
$483M
– –
-19,879
Closed -$99K
EOSEW
83
Eos Energy Enterprises Warrant
EOSEW
$29.9M
– –
-350,000
Closed -$129K
NNN icon
84
NNN REIT
NNN
$8.57B
– –
-74,200
Closed -$3.19M
OCUL icon
85
Ocular Therapeutix
OCUL
$2.34B
– –
-1,016,302
Closed -$4.09M
SPY icon
86
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
– –
-37,000
Closed -$14M
TOVX icon
87
Theriva Biologics
TOVX
$11.6M
– –
-466
Closed -$25K
TPGY.WS
88
DELISTED
TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TPGY.WS
– –
-100,000
Closed -$34K
ETACW
89
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
– –
-833,333
Closed -$108K
BRPMU
90
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
– –
-400,000
Closed -$4.04M
1 2 3
4

Similar funds

MA
McGrath & Associates Asheville, North Carolina $76.8M AUM 22.42% 1-Year Est. Return
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $76.9M AUM
QM
QVIDTVM Management The Woodlands, Texas $76.6M AUM 33.48% 1-Year Est. Return
SWM
Stapp Wealth Management Olympia, Washington $76.5M AUM 21.17% 1-Year Est. Return
BC
Bayhunt Capital Mill Valley, California $77.1M AUM
VIM
VCU Investment Management Richmond, Virginia $77.1M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $76.2M AUM 9.17% 1-Year Est. Return
SRA
Summit Rock Advisors New York $76.1M AUM

MSD Partners's Q3 2022 Portfolio in Review

As of Q3 2022, MSD Partners held 94 positions worth $1.24B, down 24% from $1.62B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

MSD Partners withdrew a net $46M in Q3 2022, closing 11 positions and reducing 3 holdings. Its most notable exit was Ocular Therapeutix, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 52% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, MSD Partners opened a new position in American Public Education worth $1M.

  • MSD Partners's largest Q3 2022 buy was American Public Education: 110,000 shares worth $1M.
  • MSD Partners's biggest Q3 2022 reduction was Algoma Steel, cutting an estimated $39M.
  • MSD Partners fully exited Ocular Therapeutix in Q3 2022, selling an estimated $4.09M.
  • MSD Partners's ten largest holdings make up 89% of its $1.24B portfolio in Q3 2022.
  • MSD Partners opened 1 new position and closed 11 in Q3 2022.
  • MSD Partners's portfolio value fell 24% quarter-over-quarter to $1.24B.

Based on MSD Partners's 13F filing for Q3 2022, filed 14 Nov 2022.